Salmonella septic arthritis in a patient
โ
Jean Y. Rim; Allan R. Tenorio
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 56 KB
๐ 2 views
The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of